Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc TRIB is 20.32%. Trinity Biotech's ROE for the same period is 10.69%. The trailing-twelve-month profit margin at Meridian Bioscience VIVO is 17.59%. Meridian Bioscience's operating margin for the same period is 27.44%. The trailing-twelve-month profit margin at IDEXX Laboratories IDXX is 13.31%. IDEXX Laboratories' revenue for the same period is $1.27 billion. The trailing-twelve-month profit margin at Neogen NEOG is 12.23%. Neogen's PEG ratio is 1.93.